{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:36:43Z","timestamp":1777934203320,"version":"3.51.4"},"reference-count":6,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2012,3,26]],"date-time":"2012-03-26T00:00:00Z","timestamp":1332720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1177\/1078155212442560","type":"journal-article","created":{"date-parts":[[2012,3,26]],"date-time":"2012-03-26T21:36:05Z","timestamp":1332797765000},"page":"445-447","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Coadministration of 5% glucose solution has a decrease in bendamustine-related vascular pain grade"],"prefix":"10.1177","volume":"18","author":[{"given":"Toshihisa","family":"Nakashima","sequence":"first","affiliation":[{"name":"Department of Pharmacy, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Kido","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Okikawa","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuo","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Hosokawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Kozawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Niimi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Kiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2012,3,26]]},"reference":[{"key":"bibr1-1078155212442560","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01635.x"},{"key":"bibr2-1078155212442560","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24714"},{"key":"bibr3-1078155212442560","unstructured":"Bendamustine Side Effects,http:\/\/www.drugs.com\/sfx\/bendamustine-side-effects.html(accessed 15 December 2011)"},{"key":"bibr4-1078155212442560","unstructured":"Prescribing Information from the PMDA about TREAKISYM\u00ae (bendamustine hydrochloride), http:\/\/www.info.pmda.go.jp\/downfiles\/ph\/PDF\/341209_4219405D1021_1_01.pdf (accessed 15 December 2011)."},{"key":"bibr5-1078155212442560","unstructured":"Prescribing Information from the FDA about TREANDA\u00ae (bendamustine hydrochloride), http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/022249s005lbl.pdf (accessed 15 December 2011)."},{"key":"bibr6-1078155212442560","doi-asserted-by":"publisher","DOI":"10.1021\/js970315l"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155212442560","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1078155212442560","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155212442560","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:14:34Z","timestamp":1777688074000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1078155212442560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,26]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1177\/1078155212442560"],"URL":"https:\/\/doi.org\/10.1177\/1078155212442560","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,26]]}}}